Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00606424
Show Display Options
Rank Status Study
1 Completed An Exploratory, Open Label, Single Center Study of [F-18]HX4
Condition: Head and Neck Cancer
Intervention: Drug: 20 mCi dose for a 50 kg individual of [F-18]HX4

Indicates status has not been verified in more than two years